Fairfield General Hospital

Bury, Great Britain BL9 7TD

0 studies enrolling now · 3 studies all time

What they study most

Ulcerative Colitis, Ulcerative Colitis Chronic

Studies at this site

• A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed